McLaughlin Melissa plan to sell securities of ALNYLAM PHARMACEUTICALS, INC. under Form 144

McLaughlin Melissa filed Form 144 to notify SEC of plan to sell 2286 units of ALNYLAM PHARMACEUTICALS, INC. securities around 2026-04-06, with aggregate market value of $731,748.60. The total outstanding units is 132623144.0. The amount planned to be sold represents 0.00% of total outstanding units;